Press Releases

WASHINGTON, DC – Today, Neurology – the official journal of the American Academy of Neurology and a leading peer-reviewed publication - published a groundbreaking study from researchers at the Rush Alzheimer’s Disease Center in Chicago that attributes more than 500,000 deaths in 2010 to Alzheimer’s disease – an amount more than six times the number reported by the Centers for Disease Control (CDC).

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease and the New York Academy of Sciences today convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer’s Platform (GAP),

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease today announced that Home Instead Senior Care© – the world's leading provider of in-home care services for seniors will join the CEOi to advance the quality of care for those suffering fro

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease today announced that Takeda Pharmaceutical Company Limited ("Takeda") will join the CEOi as part of its effort to spur innovations in research and accelerate a means of prevention for Alzheimer’s and Dementia, building momentum behind the G8’s com

USAgainstAlzheimer’s Applauds New Alzheimer’s Research Funding through Accelerating Medicines Partnership (AMP)

USAgainstAlzheimer’s will seek to advance the research goals of AMP as a member of the initiative’s steering committee

Pages

^ Back to Top